{
    "2019-04-22": [
        [
            {
                "time": "",
                "original_text": "医疗保健：医药生物业周报 荐6股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "医药生物",
                        "周报",
                        "荐股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医保目录调整方案落地，创新药放量预期加速｜【光大医药·周报】",
                "features": {
                    "keywords": [
                        "医保目录",
                        "调整方案",
                        "创新药",
                        "放量预期",
                        "光大医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "连拉11个涨停！年营收900亿巨头！暴跌59%又是啥情况？ 盈利能力下降",
                "features": {
                    "keywords": [
                        "涨停",
                        "营收",
                        "巨头",
                        "暴跌",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【天风医药】一周医讯：医药后市更值得期待，持续关注“三条主线”",
                "features": {
                    "keywords": [
                        "天风医药",
                        "医讯",
                        "后市",
                        "三条主线"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "3200点拉锯战酝酿变盘 从三大数据探寻多头主力新动向",
                "features": {
                    "keywords": [
                        "3200点",
                        "拉锯战",
                        "变盘",
                        "三大数据",
                        "多头主力"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}